245 related articles for article (PubMed ID: 28849275)
1. Increased levels of sodium chloride directly increase osteoclastic differentiation and resorption in mice and men.
Wu L; Luthringer BJC; Feyerabend F; Zhang Z; Machens HG; Maeda M; Taipaleenmäki H; Hesse E; Willumeit-Römer R; Schilling AF
Osteoporos Int; 2017 Nov; 28(11):3215-3228. PubMed ID: 28849275
[TBL] [Abstract][Full Text] [Related]
2. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
4. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures.
Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM
J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876
[TBL] [Abstract][Full Text] [Related]
5. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
6. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
7. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
Chang CC; Tsai YH; Liu Y; Lin SY; Liang YC
Rheumatology (Oxford); 2015 Oct; 54(10):1913-22. PubMed ID: 25998451
[TBL] [Abstract][Full Text] [Related]
8. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
9. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
10. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY
Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364
[TBL] [Abstract][Full Text] [Related]
11. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
12. SLIT2 inhibits osteoclastogenesis and bone resorption by suppression of Cdc42 activity.
Park SJ; Lee JY; Lee SH; Koh JM; Kim BJ
Biochem Biophys Res Commun; 2019 Jun; 514(3):868-874. PubMed ID: 31084928
[TBL] [Abstract][Full Text] [Related]
13. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.
Hattersley G; Chambers TJ
Endocrinology; 1989 Sep; 125(3):1606-12. PubMed ID: 2547591
[TBL] [Abstract][Full Text] [Related]
15. A novel culture system to generate osteoclasts and bone resorption using porcine bone marrow cells: role of M-CSF.
Scheven BA; Milne JS; Robins SP
Biochem Biophys Res Commun; 1997 Feb; 231(1):231-5. PubMed ID: 9070255
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
Cong F; Liu J; Wang C; Yuan Z; Bi L; Liang J; Su K; Qiu Y; Song T; Fan J; Chao G
Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine affects bone resorption both in vitro and in vivo.
Both T; Zillikens MC; Schreuders-Koedam M; Vis M; Lam WK; Weel AEAM; van Leeuwen JPTM; van Hagen PM; van der Eerden BCJ; van Daele PLA
J Cell Physiol; 2018 Feb; 233(2):1424-1433. PubMed ID: 28556961
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro.
Cantley MD; Fairlie DP; Bartold PM; Rainsford KD; Le GT; Lucke AJ; Holding CA; Haynes DR
J Cell Physiol; 2011 Dec; 226(12):3233-41. PubMed ID: 21344383
[TBL] [Abstract][Full Text] [Related]
19. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
Shui C; Riggs BL; Khosla S
Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
[TBL] [Abstract][Full Text] [Related]
20. Effect of prostaglandins E1, E2, and F2 alpha on osteoclast formation in mouse bone marrow cultures.
Collins DA; Chambers TJ
J Bone Miner Res; 1991 Feb; 6(2):157-64. PubMed ID: 1851370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
